A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities

Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases

(2010) C. Lindberg et al.   ACTA NEUROLOGICA SCANDINAVICA

What determines quality of life in inclusion body myositis?

(2010) R. Sadjadi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis

(2009) M. C. Dalakas et al.   BRAIN

Detecting dysphagia in inclusion body myositis

(2009) F. M. Cox et al.   JOURNAL OF NEUROLOGY

Dysphagia in Inclusion Body Myositis

(2008) Terry H. Oh et al.   AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION

Sporadic inclusion body myositis: Phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases

(2008) M Needham et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY